InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (26 ops.)
Discover the detailed record of transactions filed by TREACE JAMES T, Director. Officer active across 1 companies, notably Treace Medical Concepts, INC.. Cumulatively, 30 reports have been recorded. Total volume traded: €11.7m. The latest transaction was filed on 12 May 2026 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations30 total
US$79,65443,000 shares@ US$1.85240.046% mcap3.0% of flow
Common Stock
SEC:0001193125-26-224391·
Ideal exit: 6 Feb 2027 (T+270)
€79,65443,000 shares@ €1.85240.046% mcap1.5% of flow
Common Stock
SEC:0001193125-26-224391:0·
Ideal exit: 6 Feb 2027 (T+270)
€267,92220,809 shares@ €12.87530.16% mcap4.2% of flow
Common Stock
SEC:0001567619-22-013208:0·
€435,42630,313 shares@ €14.36430.25% mcap6.8% of flow
Common Stock
SEC:0001567619-22-011883:0·
0450,000 shares0
Common Stock
SEC:0001567619-22-006925:0·
033,875 shares0
Common Stock
SEC:0001567619-22-006730:0·
€613,18236,144 shares@ €16.9650.36% mcap21.4% of flow
Common Stock
SEC:0001567619-22-001384·
€613,18236,144 shares@ €16.9650.36% mcap9.5% of flow
Common Stock
SEC:0001567619-22-001384:0·
€23,2891,563 shares@ €14.90030.013% mcap0.8% of flow
Common Stock
SEC:0001567619-21-022714·
€296,38319,760 shares@ €14.99920.17% mcap11.3% of flow
Common Stock
SEC:0001567619-21-022717·
€23,2891,563 shares@ €14.90030.013% mcap0.4% of flow
Common Stock
SEC:0001567619-21-022714:0·
€296,38319,760 shares@ €14.99920.17% mcap5.7% of flow
Common Stock
SEC:0001567619-21-022717:0·
€337,27823,390 shares@ €14.41980.20% mcap11.8% of flow
Common Stock
SEC:0001567619-21-022541·
€601,86241,710 shares@ €14.42970.35% mcap11.5% of flow
Common Stock
SEC:0001567619-21-022542:0·
€601,86241,710 shares@ €14.42970.35% mcap22.9% of flow
Common Stock
SEC:0001567619-21-022542·
€337,27823,390 shares@ €14.41980.20% mcap5.2% of flow
Common Stock
SEC:0001567619-21-022541:0·
€219,31515,719 shares@ €13.95220.13% mcap7.7% of flow
Common Stock
SEC:0001567619-21-022459·
€219,31515,719 shares@ €13.95220.13% mcap3.4% of flow
Common Stock
SEC:0001567619-21-022459:0·
€312,28022,311 shares@ €13.99670.18% mcap6.0% of flow
Common Stock
SEC:0001567619-21-022460:0·
€312,28022,311 shares@ €13.99670.18% mcap11.9% of flow
Common Stock
SEC:0001567619-21-022460·
€1m74,526 shares@ €14.25840.62% mcap16.5% of flow
Common Stock
SEC:0001567619-21-022289:0·
€1m74,526 shares@ €14.25840.62% mcap37.1% of flow
Common Stock
SEC:0001567619-21-022289·
€851,53852,354 shares@ €16.2650.49% mcap32.5% of flow
Common Stock
SEC:0001567619-21-021184·
€851,53852,354 shares@ €16.2650.49% mcap16.2% of flow
Common Stock
SEC:0001567619-21-021184:0·
€260,25615,854 shares@ €16.41580.15% mcap4.0% of flow
Common Stock
SEC:0001567619-21-021185:0·
25 of 30 declarations
About TREACE JAMES T
James T. Treace is an executive at Treace Medical Concepts, Inc.
